Retraction notice (Biological Psychiatry (2013) 74(5) (348–356), (S0006322313003557), (10.1016/j.biopsych.2013.04.009));5-lipoxygenase activating protein reduction ameliorates cognitive deficit, synaptic dysfunction, and neuropathology in a mouse model of Alzheimer's disease

Biological Psychiatry

Volumn 74, Issue 5, 2013, Pages 348-356

  Giannopoulos, Phillip F ^a   Chu, Jin ^a   Joshi, Yash B ^a   Sperow, Margaret ^a   Li, Jin Guo ^a   Kirby, Lynn G ^a   Praticò, Domenico ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Amyloid beta; behavior; FLAP protein; tau protein; transgenic mouse models

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN INHIBITOR; CYCLIN DEPENDENT KINASE 5; GAMMA SECRETASE; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; MALE; MEMORY; MOUSE; NERVE CELL PLASTICITY; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 84882288993     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2024.05.001     Document Type: Erratum

References (25)

1. M. Citron Alzheimer's disease: Strategies for disease modification Nat Rev Drug Discov 9 2010 387 398
2. S.T. DeKosky, and S.W. Scheff Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity Ann Neurol 27 1990 457 464
3. S.W. Scheff, S.A. Scott, and S.T. DeKosky Quantitation of synaptic density in the septal nuclei of young and aged Fischer 344 rats Neurobiol Aging 12 1991 3 12
4. D.J. Selkoe Alzheimer's disease is a synaptic failure Science 298 2002 789 791
5. J.J. Palop, J. Chin, and L. Mucke A network dysfunction perspective on neurodegenerative diseases Nature 443 2006 768 773
6. S.W. Scheff, D.A. Price, F.A. Schmitt, S.T. Dekosky, and E.J. Mufson Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment Neurology 68 2007 1501 1508
7. O. Radmark, O. Werz, D. Steinhilber, and B. Samuelsson 5-Lipoxygenase: Regulation of expression and enzyme activity Trends Biochem Sci 32 2007 332 341
8. J. Chu, and D. Praticò Involvement of 5-lipoxygenase activating protein in the amyloidotic phenotype of an Alzheimer's disease mouse model J Neuroinflammation 9 2012 2094 2099
9. J. Chu, and D. Praticò Pharmacological blockade of 5-lipoxygenase improves the amyloidotic phenotype of an Alzheimer's disease transgenic mouse model Am J Pathol 178 2011 1762 1769
10. O. Firuzi, J. Zhuo, C.M. Chinnici, T. Wisniewski, and D. Praticò 5-Lipoxygenase gene disruption reduces amyloid-β pathology in a mouse model of Alzheimer's disease FASEB J 22 2008 1169 1178
11. S. Oddo, A. Caccamo, J.D. Shepherd, M.P. Murphy, T.E. Golde, and R. Kayed Triple transgenic model of Alzheimer's disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction Neuron 39 2003 409 421
12. X. Diamant, M.C. Timmersa, H. van der Venna, B.S. Friedman, M. De Smet, and M. Depre The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo J Aller Clin Immunol 95 1995 42 51
13. R.S. Byrum, J.L. Goulet, R.J. Griffiths, and B.H. Koller Role of the 5-lipoxygenase-activating protein (FLAP) in murine acute inflammatory responses J Exp Med 185 1997 1065 1075
14. H. Yang, J. Zhuo, J. Chu, C. Chinnici, and D. Pratico Amelioration of the Alzheimer's disease phenotype by absence of 12/15-lipoxygenase Biol Psychiatry 68 2010 922 929
15. J.M. Zhuo, G.S. Portugal, W.D. Kruger, H. Wang, and T.J. Gould Diet-induced hyperhomocysteinemia increases amyloid-beta formation and deposition in a mouse model of Alzheimer's disease Curr Alzheimer Res 7 2010 140 149
16. C. Andorfer, Y. Kress, M. Espinoza, R. De Silva, K.L. Tucker, and Y.A. Barde Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms J Neurochem 86 2003 582 590
17. R.S. Zucker, and W.G. Regehr Short-term synaptic plasticity Annu Rev Physiol 64 2002 355 405
18. T.V.P. Bliss, and G.L. Collingridge A synaptic model of memory: Long-term potentiation in the hippocampus Nature 361 1993 31 39
19. J. Chu, P.F. Giannopoulos, C. Ceballos-Diaz, T.E. Golde, and D. Pratico 5-Lipoxygenase gene transfer worsens memory, amyloid, and tau brain pathologies in a mouse model of Alzheimer disease Ann Neurol 72 2012 1762 1769
20. D.W. Dickson, H.A. Crystal, C. Bevona, W. Honer, I. Vincent, and P. Davies Correlations of synaptic and pathological markers with cognition of the elderly Neurobiol Aging 16 1995 285 304
21. E. Masliah, M. Mallory, M. Alford, R. DeTeresa, R. Hansen, and L.A. Mckeel Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease Neurology 56 2001 127 129
22. C.I. Sze, J.C. Troncoso, C. Kawas, P. Mouton, D.L. Price, and L.J. Martin Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease J Neuropathol Exp Neurol 56 1997 933 944
23. R.D. Terry, E. Masliah, E. Salmon, D.P. Butters, N. DeTeresa, and R. Hill Physical basis of cognitive alterations in Alzheimer's disease synapse loss is the major correlate of cognitive impairment Ann Neurol 30 1991 572 580
24. N.A. Hessler, A.M. Shirke, and R. Malinow The probability of transmitter release at a mammalian central synapse Nature 366 1993 569 572
25. E.R. Kandel, and J.H. Schwartz Molecular biology of learning: Modulation of transmitter release Science 218 1982 433 443